Vienna, Austria

ESTRO 2025

Session

Sunday
May 04
09:00 - 10:00
Business 1-2
Haematology & Palliation
Eva Oldenburger, Belgium;
GABRIELE SIMONTACCHI, Italy
Mini-Orals are presented at one of the sessions scheduled in the two mini-oral theatres. Each author will present a 4-slide PowerPoint orally for 4 minutes, followed by 3 minutes for discussion. Sessions will be recorded and made available via the online platform and mobile app.
Mini-Orals
Clinical
09:00 - 09:07
Decrease of metabolic active tumour volume of target- and unintentionally irradiated lesions after bridging radiotherapy prior to CAR T-cell therapy
Anne Niezink, The Netherlands
E25-1764
09:07 - 09:14
5-5-5 ABRT (Adaptive Bridging Radiation Therapy) – Artificial Intelligence Enters the CAR (-T) in Rel/Ref Large B-Cell Lymphoma (Trial: NCT06004167)
Chirayu Patel, USA
E25-3766
09:14 - 09:21
Improved organ-sparing using intensity modulated proton therapy combined with breath-hold for mediastinal lymphoma: a four-way plan comparison study
Bastiaan Ta, The Netherlands
E25-3936
09:21 - 09:28
Efficacy and toxicity of low dose radiotherapy for mucosa associated lymphoid tissue (MALT) lymphoma of the salivary glands
Jessica Brady, United Kingdom
E25-4521
09:28 - 09:35
Diagnostic Imaging for VERTebral metastases (DIVERT) – Results of a prospective patient study
Madeleine Van de Kleut, Canada
E25-1153
09:35 - 09:42
Unexpected results from the multicenter prospective ARISE study: cancer type is the predominant factor in non-cancer pain management.
Costanza Maria Donati, Italy
E25-3541
09:42 - 09:49
An international Delphi consensus study to develop a revised acute radiation dermatitis scoring tool
Sze Wa Tse, Hong Kong (SAR) China
E25-3336
09:49 - 09:56
Real-world reirradiation treatment and disease characteristics: interim analysis of the prospective observational E2-RADIatE ReCare cohort
Jonas Willmann, Switzerland
E25-3204